stock_BIIB r_down	sector:1 has:1 likes:1 said:1 multiple:1 additional:1 acquired:1 highs:1 million:1 sclerosis:1 citing:1 still:1 record:1 near:1 treatment:1 interest:1 's:1 stocks:1 valuation:1 downgraded:1 $:1
stock_BIIB r_up	loss:1 after:1 improved:1 declines:1 company:1 surges:1 results:1 while:1 public:1 drag:1 quarter:1 boost:1 its:1 reporting:1 first:1
stock_BIIB r_down	therapeutics:2 develop:2 license:2 deal:2 collaboration:2 unveiled:2 inherited:1 conditions:1 structure:1
stock_BIIB r_up	firm:1 transition:1 assist:1 remain:1 but:1 acting:1 names:1 until:1
stock_BIIB r_down	saying:1 deal:1 private:1 strategic:1 drug:1 skin:1 investment:1 cancer:1 $:1 jumped:1 its:1 lifts:1 pursuing:1 new:1 boost:1 seeks:1 firm:1 buy:1 surges:1 early:1 actions:1 report:1 approval:1 rises:1 after:2 billion:1 16:1 up:1 value:1 while:1 changes:1 maker:1
stock_BIIB r_up	lowers:1 holiday:1 while:1 after:1 20:1 accelerates:1 car:1 surges:1 stronger-than-expected:1 sales:2 its:1 quarter:1 critical:1 earnings:1 tumbles:1 estimate:1 strong:1 skids:1
stock_BIIB r_up	fourth-quarter:1 said:1 's:1 revenue:1 items:1 related:1 34:2 other:1 fell:1 growth:1 earnings:1 expenses:1 its:1 acquisition:1 recent:1
stock_BIIB r_down	fourth-quarter:2 grew:2 's:2 revenue:1 profit:2 boost:1 57:2 sales:2 company:1 said:1 multiple-sclerosis:2 treatment:2 biotechnology:1 strong:1 continued:1 its:3
stock_BIIB r_down	biotech:1 lifted:1 $:2 price:1 377:1 target:1
stock_BIIB r_up	sector:2 gains:1 highs:1 lag:1 utilities:1 rest:1 falls:1 only:1 yields:2 gain:1 stocks:1 500’s:1 stumble:1 market:1
stock_BIIB r_down	session:1 disease:1 's:4 help:1 deal:1 develop:1 companies:2 two:1 shares:1 trade:1 actively:1 expected:1 reached:1 treatments:1 has:1 experimental:1 said:1
stock_BIIB r_up	anticipation:1 gains:2 debut:1 loses:1 while:1 market:1 surrenders:1 earlier:1 rises:1 momentum:1 stock:1
stock_BIIB r_up	limited:1 health-care:1 economic:1 year:1 vote:1 market:1 positive:1 shares:1 freezes:1 asset:1 upbeat:1 insights:1 500:1 stock:1 his:1 's:1 bans:1 rise:1 visa:1 stocks:1 data:1 governments:1 reaction:1 rallies:1 following:1
stock_BIIB r_down	worldwide:1 said:1 rights:1 jumped:1 company:1 after:1 potential:1 broad:1 has:1 antibody:1
stock_BIIB r_down	streak:2 biotech:1 outlook:1 executive:1 high:1 say:1 session:1 weighing:1 its:2 sector:1 while:1 winning:2 traders:1 much:1 extends:2 stock:1 upbeat:1 price:1 more:1 complaint:1 's:1 sinks:1 sixth:1 company:1 after:1 down:1 taking:1 firing:1 drug:1 chief:1 high-flying:1 analysts:1 plunges:1
stock_BIIB r_down	sector:2 investors:2 health-care:1 second:2 session:2 's:1 declined:1 out:2 selloff:2 negative:2 bug:1 also:2 more:1 edged:1 weakness:1 24-hour:1 focused:2 stocks:1 data:2 than:1 lower:1 like:1 straight:2 while:2 economic:2 biotechnology:2
stock_BIIB r_down	1.2:1 bounce:1 session:1 caution:1 follow:1 still:1 dented:1 which:1 finish:1 gains:1 week’s:1 but:1 lows:1 fall:1 prices:1 news:1 stocks:2 day:1 lower:1 off:1 last:1 light:1 prevails:1 drop:1 economic:1 skids:1
stock_BIIB r_down	sector:1 biotech:1 good:1 look:1 once-hot:1 sign:1 ugly:1 which:1 not:1 broader:1 market:1
stock_BIIB r_up	major:1 do:1 suddenly:1 declines:1 into:1 move:1 shed:1 competition:1 month:1 shares:1 have:1 year:1 technology:1 its:2 vulnerable:1 concern:1 said:1 would:1 no:1 long:1 next:1 their:1 which:1 appeal:1 more:1 lowest:1 independent:1 product:1 health-care:1 closed:1 business:1 company:1 diversified:1 wrong:1 stocks:1 spin:1 than:1 off:1 pressured:1 lost:1 level:1 considered:1 could:1 lines:1 drug:1 so:1 biotechnology:1 latest:1
stock_BIIB r_down	months:1 sees:1 selloff:1 down:1 authorities:1 including:1 markets:1 rally:1 its:1 market:1 out:1 index:1 end:1 spending:1 positive:1 review:1 generally:1 also:1 other:1 treatment:2 inherited:1 has:1 type:1 stock:1 week:2 disorder:1 's:2 gains:1 after:2 early:1 most:1 drag:1 worst:1 week-long:1 regulatory:1 pares:1 stocks:1 data:1 approved:1 several:1 hemophilia:2 17:1 largely:1 biotechs:1 losses:1 morning:1 common:1 following:1 under:1 consumer:1
stock_BIIB r_up	they:1 producer:1 trade:3 report:1 see:1 session:3 275:1 its:1 developer:1 proposed:1 drubbing:1 stake:1 shares:2 approved:1 also:1 treatment:1 premarket:1 inherited:1 expected:2 has:1 type:1 week’s:1 earnings:1 acquire:1 's:4 increased:1 get:1 company:1 million:1 watch:1 like:1 quarterly:1 ethanol:1 active:1 stocks:2 surged:1 4.25:1 after:1 $:2 last:1 hemophilia:2 real-estate:1 largely:1 could:1 companies:2 35:1 actively:2 common:1 attention:1 disorder:1 names:1
stock_BIIB r_up	rallied:1 sector:1 strong:1 's:1 broadly:1 lackluster:1 months:1 three:1 beaten-down:1 day:1 biotechnology:1 trading:1 gain:1 capping:1 led:1 quarter:1 final:1
stock_BIIB r_up	sector:1 include:1 volatile:1
stock_BIIB r_down	lowering:1 factors:1 biotechs:1 central-bank:1 same:1 also:1 yields:1 policies:1
stock_BIIB r_up	operations:2 division:2 giant:1 has:1 run:2 another:1 business:1 pharmaceutical:1 --:2 veteran:2 move:1 head:1 generics:1 manager:2 hired:1 promoting:2 key:1 executive:1 portfolio:1 eye-care:2 its:5
stock_BIIB r_down	fourth-quarter:2 old:1 impacts:1 revenue:1 adjustments:1 retailer:1 sales:1 trade:2 session:2 one-time:1 its:2 5.2:1 said:1 $:1 objectives:1 recorded:1 shares:2 children:1 3:1 growth:1 earnings:2 premarket:1 under:1 expected:2 has:1 treatment:1 11:1 's:5 primary:1 fell:3 despite:1 such:1 years:1 continued:1 debt-extinguishment:1 fiscal:2 12:1 hemophilia:1 55:1 items:1 study:1 drop:1 companies:2 charges:1 severe:1 actively:2
stock_BIIB r_down	control:1 direction:1 right:1 's:1 difficult:1 reverses:1 thing:1 gathers:1 if:1 can:1 impossible:1 works:1 steam:1 wonders:1
stock_BIIB r_up	biotech:1 keys:1 week’s:1 companies:1 market:1 not:1 news:1 writes:1 bigger:1 stock:1
stock_BIIB r_up	spawn:1 biotech:2 says:1 investors:1 among:1 find:1 related:1 manager:1 officials:1 's:2 makers:1 relationships:1 decline:1 federal:1 next:1 looking:1 state:1 earnings:1 which:1 has:1 disclosed:1 first-quarter:1 love:1 big:1 subpoenas:1 pharmacy-benefit:1 reported:1 received:1 12:1 could:1 companies:1 likely:1 drug:1 stock:1
stock_BIIB r_down	month:1 looks:1 rally:1 bear-market:1 than:1 current:1 which:1 9:1 weeks:1 more:1 exchange:1 dive:1 took:1 fund:1 levels:1 coming:1 technician:1 now:1 poised:1 last:1 according:1 traded:1
stock_BIIB r_down	sees:1 bullishness:1 investing:1 warns:1 newsletters:1 bearish:1 against:1
stock_BIIB r_down	stocks:1 momentum-play:1 leading:1 attracts:1 attention:1 rejected:1 leads:1 while:1 lift:1 closely:1 watched:1 rally:2 buyout:1 rises:1 proposal:1 momentum:1 after:1
stock_BIIB r_up	ago:1 stocks:1 gains:1 racked:1 big:1 up:1 has:1 decades:1 bought:1
stock_BIIB r_up	their:2 dominating:1 way:1 areas:1
stock_BIIB r_up	booming:1 biotech:1 pipeline:1 20:1 drugs:1 price:1 giant:1 premium:1 's:1 justify:1 than:1 more:1
stock_BIIB r_down	purchase:1 over:1 lead:1 into:2 after:2 its:1 while:1 jumping:1 pending:1 bidding:1 rallies:2 following:1 news:1 entered:1 rises:1 war:1 500:1 chase:1
stock_BIIB r_up	venture-capital:1 ``:1 hiring:1 generation:1 biotechs:1 work:1 outsourcing:1 virtual:1 research:1 '':1 frugal:1 overhead:1 lab:1 pursuing:1 consultants:1 new:1 keep:1 down:1
stock_BIIB r_up	beaten-up:1 sector:1 key:1 picks:1
stock_BIIB r_down	available:1 right:1 adults:1 partnership:1 expects:1 including:1 children:1 said:1 leading:1 review:1 which:1 under:1 has:3 final:1 development:2 's:2 approval:1 manufacturing:1 approved:1 several:1 rights:1 assume:1 countries:1 drug:2 first:1
stock_BIIB r_up	week:1 everyone:1 adults:1 meetings:1 expects:1 trade:2 course:1 session:2 deadlines:1 another:1 our:1 edged:1 children:1 said:1 $:1 working:1 cup:1 come:1 make:1 cope:1 please:1 shares:2 stimulation:1 2:1 treatment:1 premarket:1 routine:1 expected:2 falling:1 has:2 easier:1 hope:1 available:1 we:1 's:4 maintenance:1 resume:1 familiar:1 wonderful:1 welcome:1 spot:1 rain:1 you:1 because:1 not:1 weekend:1 approved:2 join:1 refreshing:1 region:1 dig:1 companies:2 up:1 drug:2 morning:2 actively:2 does:1 have:1 time:1 grab:1 're:1 us:1
stock_BIIB r_up	little:1 lift:1 had:1 2-for-1:1 buyback:1 shares:1 helping:1 cheer:1 program:1 split:1 year:1 has:1 bigger:1 stock:1
stock_BIIB r_up	billion:1 week:1 last:1 $:1 46:1 bid:1 laying:1 rejected:1 its:2 takeover:1 pursuit:1 rationale:1 which:1 continued:1 maker:1 out:1
stock_BIIB r_down	billion:1 pharmaceutical:1 raised:1 attempt:1 $:1 offer:1 company:1 51:1 negotiating:1 than:1 bring:1 board:1 fourth:1 table:1 's:1 its:2 more:1
stock_BIIB r_down	beneficial:1 health-care:1 tax:2 head:1 marked:1 '':1 close:1 pharmaceutical:1 two:1 their:1 health:1 ``:1 good:1 's:1 purposes:1 overseas:1 success:1 these:1 wins:1 industry:1 companies:2 deals:1 inversions:1 efforts:1 think:1 latest:1
stock_BIIB r_down	catalysts:1 have:1
stock_BIIB r_up	sector:1 operations:1 adjusted:1 revenue:1 sales:2 back:1 trade:2 helped:2 snack:1 full-year:1 actively:2 multiple-sclerosis:1 expected:2 year:1 close:1 technology:1 its:5 increased:1 closes:1 4.7:1 strong:1 missed:1 second:1 profit:1 rose:1 expectations:1 shares:2 second-quarter:2 also:1 beverage:1 health:1 earnings:5 premarket:1 quarterly:1 international:1 9.6:1 company:1 500:2 more:1 experienced:1 's:4 said:2 wide:1 jumps:1 weak:1 treatments:1 results:2 push:1 fell:2 46:1 robust:1 stocks:1 than:1 care:1 10:2 quarter:1 impressive:1 outlook:2 up:1 companies:2 drive:1 slumps:2 $:1 record:2 while:1 session:2 analysts:1 volumes:1 rallies:1 following:1 higher:1 margin:1 reduced:1 profits:1
stock_BIIB r_down	biotech:1 projection:1 investors:1 into:1 back:1 marked:1 price:1 multiple-sclerosis:1 year:1 its:2 developer:1 profit:1 rose:1 had:1 makers:1 increase:1 citing:1 other:1 health:1 earnings:2 biggest:1 clinical:1 insurers:1 share-price:1 more:1 niche:1 rise:1 's:1 blowout:1 drugs:1 boosted:1 company:1 after:2 drew:1 sales:1 quarterly:1 tripled:1 eight:1 report:1 breast-cancer:1 strong:1 than:1 posted:1 showed:1 --:1 months:1 drug:3 large:1 trial:1 promise:1 maker:1 late-stage:1
stock_BIIB r_up	looking:1 drugs:1 globe:1 travels:1 fund:1 manager:1
stock_BIIB r_up	25:1 could:1 rise:1 results:1 shares:1 forecast:1 cheering:1 restructuring:1 plan:1 upbeat:1 strong:1 second-quarter:1
